Meeting
2023 ASCO Breakthrough
Effects of supervised exercise and self-managed psychosexual therapy on sexual health in men with prostate cancer: A randomized clinical trial.
Authors
Daniel Abido Galvao
Edith Cowan University, Perth, Australia
Daniel Abido Galvao , Suzanne K Chambers , Dennis R Taaffe , Prue Cormie , Oliver Schumacher , Robert Alexander Gardiner , Nigel Spry , Pedro Lopez , David John Joseph , Colin Tang , Dickon Hayne , Robert Usher Newton
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Breast Cancer,Central Nervous System Tumors,Developmental Therapeutics,Genitourinary Cancer,Hematologic Malignancies,Thoracic Cancers,Other Malignancies or Topics
Sub Track
Local Disease
Clinical Trial Registration Number
ACTRN12613001179729
Citation
JCO Global Oncology 9, 2023 (suppl 1; abstr 71)
DOI
10.1200/GO.2023.9.Supplement_1.71
Abstract #
71
Poster Bd #
D7
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Prostate Cancer Supportive Care (PCSC) Program: A model for meeting an unmet need for patients with PC.
First Author: Celestia S. Higano
Poster
2023 ASCO Breakthrough
Effect of exercise mode specificity on quality of life in prostate cancer patients undergoing androgen suppression.
First Author: Dennis R Taaffe
Poster
2023 ASCO Annual Meeting
Exercise to enhance cardiovascular health among Black patients with prostate cancer with androgen deprivation therapy: The POWER trial.
First Author: Dong-Woo Kang
Poster
2023 ASCO Genitourinary Cancers Symposium
A phase II trial modifying metabolic syndrome and cardiovascular risk for patients with prostate cancer on ADT using a risk factor modification program and continuous Fitbit monitoring (ProTrio).
First Author: Andrew Warren Hahn